1-1 of 1
Li Shuli
Close
Save search
Sort by
Journal Articles

Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with FLT3-ITD AML

Free
Yi-Bin Chen, MD, Li Shuli, PhD, Lane A. Andrew, MDPhD, Christine Connolly, Candice Del Rio, NP, Betsy Valles, NP, Morgan Curtis, Karen K. Ballen, MD, Corey S Cutler, MD MPH, Bimalangshu R Dey, MD, Areej El-Jawahri, MD, Amir T. Fathi, MD, Vincent T Ho, MD, Amy Joyce, NP, Steven L. McAfee, MD, Michelle A Rudek, Trivikram Rajkhowa, Sigitas Verselis, PhD, Joseph H. Antin, MD, Thomas R. Spitzer, MD, Mark Levis, MD PhD, Robert J. Soiffer, MD
Journal: Blood
Blood (2014) 124 (21): 671.
https://doi.org/10.1182/blood.V124.21.671.671
Published: 2014